Molecular Stethoscope

OverviewSuggest Edit

Molecular Stethoscope is an early stage, molecular diagnostics company engaged in transcriptomic research and development. Tissue-specific cell-free circulating RNA is a newly developed area for molecular diagnosis. Based on this non-invasive approach, Molecular Stethoscope aims to transform healthcare by providing early insight into a patient’s healthy versus disease state.

TypePrivate
Founded2015
HQSan Diego, CA, US
Websitemolecularstethoscope.com

Latest Updates

Employees (est.) (Jun 2021)3
Cybersecurity ratingBMore

Key People/Management at Molecular Stethoscope

Tina Nova

Tina Nova

President & CEO
Mike Nerenberg

Mike Nerenberg

SVP & Chief Medical Officer
Brent Vetter

Brent Vetter

Senior Director, Finance
John Aballi

John Aballi

Senior Director, Lab Operations
Yue Zhao

Yue Zhao

Director, Bioinformatics
David Cornfield

David Cornfield

Stanford Children’s Hospital
Show more

Molecular Stethoscope Office Locations

Molecular Stethoscope has an office in San Diego
San Diego, CA, US (HQ)
10835 Rd to the Cure
Show all (1)

Molecular Stethoscope Financials and Metrics

Summary Metrics

Founding Date

2015

Molecular Stethoscope total Funding

$8.2 m

Molecular Stethoscope latest funding size

$8.2 m

Time since last funding

4 years ago

Molecular Stethoscope investors

Molecular Stethoscope's latest funding round in January 2017 was reported to be $8.2 m. In total, Molecular Stethoscope has raised $8.2 m
Show all financial metrics

Molecular Stethoscope Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

SecurityScorecard logo

Molecular Stethoscope Online and Social Media Presence

Embed Graph

Molecular Stethoscope News and Updates

Molecular Stethoscope Announces Publication of its NAFLD/NASH Study in the American Journal of Physiology - Gastrointestinal and Liver Physiology

Circulating cell-free mRNA in blood reflective of NAFLD/NASH liver pathology PALO ALTO, Calif., Feb. 23, 2021 /PRNewswire/ -- Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of its human proof-of-concept study describing the stratification of...

Molecular Stethoscope Announces Completion and Publication of its Alzheimer's Disease Study in Science Advances

PALO ALTO, Calif., Dec. 14, 2020 /PRNewswire/ -- Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of a human proof-of-concept study for Alzheimer's Disease using its proprietary cell-free messenger RNA (cf-mRNA)-Artificial Intelligence...

Molecular Stethoscope Frequently Asked Questions

  • When was Molecular Stethoscope founded?

    Molecular Stethoscope was founded in 2015.

  • Who are Molecular Stethoscope key executives?

    Molecular Stethoscope's key executives are Tina Nova, Mike Nerenberg and Brent Vetter.

  • How many employees does Molecular Stethoscope have?

    Molecular Stethoscope has 3 employees.

  • Who are Molecular Stethoscope competitors?

    Competitors of Molecular Stethoscope include SYSTAAQ Diagnostic Products, Alpha IVD and Triplet Therapeutics.

  • Where is Molecular Stethoscope headquarters?

    Molecular Stethoscope headquarters is located at 10835 Rd to the Cure, San Diego.

  • Where are Molecular Stethoscope offices?

    Molecular Stethoscope has an office in San Diego.

  • How many offices does Molecular Stethoscope have?

    Molecular Stethoscope has 1 office.